CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP,Chief Info&Digital Officer sold 7,509 shares at $116.82 ($877,222)
- 4 Exercise or conversion Sr. VP Fince-Global Controller acquired 930 shares (option exercise)
- 4 Exercise or conversion Executive VP & President, MRL acquired 1,062 shares (option exercise)
- 4 Exercise or conversion EVP & CFO acquired 866 shares (option exercise)
- 4 Exercise or conversion President, U.S. Market acquired 866 shares (option exercise)
- 4 Exercise or conversion SVP Chief Ethics & Com Officer acquired 643 shares (option exercise)
- 4 Exercise or conversion EVP - Chief Strategy Officer acquired 866 shares (option exercise)
- 4 Open-market sale EVP&Pres, Merck Animal Heallth sold 141,599 shares at an average $115.55 ($16,361,593)
Page 14 of 99 · 1,973 filings